Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
NEUTRAL SIGNAL
██.█% Sign up free to reveal

Zentalis Pharmaceuticals, Inc. (ZNTL) AI Forecast

Our AI analyzed Zentalis Pharmaceuticals, Inc.. Create a free account to see the 90-day price prediction.

✓ Free account • ✓ 30-day free trial

$ZNTL Neutral Signal Full forecast available
Sign Up Free

Zentalis Pharmaceuticals, Inc. (ZNTL) Stock Forecast 2025

Zentalis Pharmaceuticals, Inc. (ZNTL) AI Stock Price Forecast & Investment Analysis

Zentalis Pharmaceuticals, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Zentalis Pharmaceuticals, Inc. (ZNTL) - Comprehensive Stock Analysis & Investment Research

Deep dive into Zentalis Pharmaceuticals, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on March 20, 2026, 10:56 p.m. (UTC)

Zentalis Pharmaceuticals, Inc. Investment Summary

When evaluating whether Zentalis Pharmaceuticals, Inc. (ZNTL) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Zentalis Pharmaceuticals, Inc. (ZNTL) operates within the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. The company employs approximately 166 people. With a market capitalization of $170 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Zentalis Pharmaceuticals, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Zentalis Pharmaceuticals, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Zentalis Pharmaceuticals, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Zentalis Pharmaceuticals, Inc.

Sign Up Free
Corporate Identity

Zentalis Pharmaceuticals, Inc. (Stock Symbol: ZNTL) is a prominent company operating within the Life Sciences sector, with a specific focus on the Pharmaceutical Preparations industry. The company's shares are publicly traded on the Nasdaq exchange.

Leadership & Workforce

Detailed information about Zentalis Pharmaceuticals, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Zentalis Pharmaceuticals, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Zentalis Pharmaceuticals, Inc....

Unlock Full Company Profile

Get complete details about Zentalis Pharmaceuticals, Inc.

Sign Up Free
Revenue & Growth Analysis

Zentalis Pharmaceuticals, Inc. generates annual revenues of $26 million , representing an emerging company in its growth phase.

Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Zentalis Pharmaceuticals, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Zentalis Pharmaceuticals, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Zentalis Pharmaceuticals, Inc....

Unlock Financial Analysis

Get complete financial metrics for Zentalis Pharmaceuticals, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Zentalis Pharmaceuticals, Inc.'s AI Price Forecast

Join 10,000+ investors using our 67%+ accurate AI predictions

4,000+ Stocks Analyzed
67%+ Accuracy Rate
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Zentalis Pharmaceuticals, Inc. strategically competes in the highly dynamic Pharmaceutical Preparations marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Zentalis Pharmaceuticals, Inc. competes within the Life Sciences sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency

The company currently shows negative free cash flow of $-173 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.

Financial Strength & Leverage

Current ratio of 6.93 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.

Zentalis Pharmaceuticals, Inc. (ZNTL) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Zentalis Pharmaceuticals, Inc. stock analysis.

Deep dive into Zentalis Pharmaceuticals, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Zentalis Pharmaceuticals, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Zentalis Pharmaceuticals, Inc.: With a P/E ratio of -1.36, the market sees the stock as potentially undervalued.

P/E Ratio -1.36x
P/B Ratio 0.67x
Market Cap $170M
EPS $-2.42
Book Value/Share $3.90
Revenue/Share $0.41
FCF/Share $-1.79
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Zentalis Pharmaceuticals, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Zentalis Pharmaceuticals, Inc.: An ROE of -57.5% indicates room for improvement in shareholder value creation.

ROE -57.5%
ROA -45.8%
ROIC -49.7%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Zentalis Pharmaceuticals, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Zentalis Pharmaceuticals, Inc.: A current ratio of 6.93 indicates strong liquidity.

Current Ratio 6.93x
Quick Ratio 6.75x
D/E Ratio 0.14x
Financial Leverage 1.29x
Working Capital $317M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Zentalis Pharmaceuticals, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Zentalis Pharmaceuticals, Inc.: Free cash flow of $-173M indicates cash challenges that need attention.

Operating Cash Flow -$167M
Free Cash Flow -$173M
Capital Spending -$6M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Zentalis Pharmaceuticals, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Zentalis Pharmaceuticals, Inc.:

Receivables Turnover 0.0x
Fixed Assets Turnover 0.1x
Days Sales Outstanding 23908 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Zentalis Pharmaceuticals, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Zentalis Pharmaceuticals, Inc.: With annual revenue of $26M, Zentalis Pharmaceuticals, Inc. represents a smaller but potentially high-growth operation.

Income Statement
Total Revenue $26M
Operating Income -$16M
Net Income -$80M
R&D Expense $186M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 74%
Cash & Short-term Investments 71%
Total Liabilities 22%
Accounts Receivable 1%
Dividend & Shareholder Information
Shares Outstanding 65M
Growth Metrics (YoY)
EPS Growth -99.4%

Latest Zentalis Pharmaceuticals, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Zentalis Pharmaceuticals, Inc. (ZNTL) stock price and investment outlook.

More news available

Sign up free to read all 10 news articles and stay updated on market developments.

Sign Up Free to Read More

Zentalis Pharmaceuticals, Inc. Competitors & Peer Analysis - Life Sciences Sector

Comparative analysis of Zentalis Pharmaceuticals, Inc. against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
Aardvark Therapeutics, Inc. AARD ██% $107M x 0.9x
Abbvie Inc. ABBV ██% $362.77B 85.8x 255.5x
Abcellera Biologics Inc. ABCL ██% $1.06B -5.3x 1.1x
Abeona Therapeutics Inc. ABEO ██% $250M 3.5x 1.6x
Abbott Laboratories ABT ██% $186.62B 28.6x 3.6x
Arbutus Biopharma Corp ABUS ██% $816M -8.3x 10.5x
Abvc Biopharma, Inc. ABVC ██% $32M -0.3x 2.9x
Abivax S.A. ABVX ██% $9.75B x x
Acadia Pharmaceuticals Inc ACAD ██% $3.53B 9.0x 2.9x
Adicet Bio, Inc. ACET ██% $67M -0.4x 0.4x
Aclaris Therapeutics, Inc. ACRS ██% $445M -4.5x 4.3x
Acrivon Therapeutics, Inc. ACRV ██% $54M -2.8x 0.5x
Actuate Therapeutics, Inc. ACTU ██% $120M x 11.0x
Accustem Sciences Inc. ACUT ██% $6M x 7.6x
Acurx Pharmaceuticals, Inc. ACXP ██% $12M -0.8x 2.3x
Adagene Inc. ADAG ██% $174M x 4.6x
Adc Therapeutics Sa ADCT ██% $508M -9.2x -1.3x
Adial Pharmaceuticals, Inc. ADIL ██% $3M -0.1x 0.5x
Aditxt, Inc. ADTX ██% $400K 0.0x 0.0x
Addex Therapeutics Ltd. ADXN ██% $7M x x
Aeon Biopharma, Inc. AEON ██% $30M 6.5x x
Agios Pharmaceuticals, Inc. AGIO ██% $1.63B 3.7x 1.4x
Ainos, Inc. AIMD ██% $10M -0.4x 1.0x
Akebia Therapeutics, Inc. AKBA ██% $377M -5.4x 11.6x
Akero Therapeutics, Inc. AKRO ██% $4.38B -8.7x 4.6x
Akari Therapeutics Plc AKTX ██% $7M -2.0x 0.3x
Aldeyra Therapeutics, Inc. ALDX ██% $85M -5.1x 1.9x
Alkermes Plc. ALKS ██% $4.50B 18.6x 2.5x
Allarity Therapeutics, Inc. ALLR ██% $18M -0.2x 1.5x
Alumis Inc. ALMS ██% $3.16B x 10.5x
Alnylam Pharmaceuticals, Inc. ALNY ██% $41.67B 132.8x 52.8x
Altimmune, Inc. ALT ██% $428M -5.7x 1.9x
Alx Oncology Holdings Inc ALXO ██% $288M -0.4x 11.1x
Alzamend Neuro, Inc. ALZN ██% $7M -0.1x 3.2x
Amylyx Pharmaceuticals, Inc. AMLX ██% $1.52B -1.5x 5.0x
Amphastar Pharmaceuticals, Inc. AMPH ██% $890M 9.1x 2.0x
Amarin Corp Plc\Uk AMRN ██% $312M -4.5x 0.7x
Amneal Pharmaceuticals, Inc. AMRX ██% $3.87B 53.7x 195.5x
Anaptysbio, Inc ANAB ██% $1.75B -2.5x 47.0x
Anebulo Pharmaceuticals, Inc. ANEB ██% $44M -4.3x 5.5x
Ani Pharmaceuticals Inc ANIP ██% $1.67B 21.3x 3.1x
Anixa Biosciences Inc ANIX ██% $93M -15.0x 6.2x
Annexon, Inc. ANNX ██% $815M -4.1x 5.1x
Alto Neuroscience, Inc. ANRO ██% $719M x 4.8x
An2 Therapeutics, Inc. ANTX ██% $107M x 2.0x
Annovis Bio, Inc. ANVS ██% $73M -1.0x 4.3x
Apollomics Inc. APLM ██% $40M x x
Apellis Pharmaceuticals, Inc. APLS ██% $2.28B 101.6x 6.2x
Applied Therapeutics, Inc. APLT ██% $15M -0.7x 0.9x
Aprea Therapeutics, Inc. APRE ██% $8M -1.2x 0.7x
Apimeds Pharmaceuticals Us, Inc. APUS ██% $25M x 3.0x
Aptevo Therapeutics Inc. APVO ██% $7M -0.1x 0.4x
Aquestive Therapeutics, Inc. AQST ██% $496M -10.7x 49.2x
Arcturus Therapeutics Holdings Inc. ARCT ██% $188M -7.0x 0.9x
Ardelyx, Inc. ARDX ██% $1.34B -21.3x 8.1x
Arcutis Biotherapeutics, Inc. ARQT ██% $2.83B -6.6x 14.9x
Artelo Biosciences, Inc. ARTL ██% $5M -0.7x 7.8x
Arvinas, Inc. ARVN ██% $692M -4.8x 1.6x
Arrowhead Pharmaceuticals, Inc. ARWR ██% $7.83B 38.7x 13.8x
Aspire Biopharma Holdings, Inc. ASBP ██% $3M x x
Assembly Biosciences, Inc. ASMB ██% $451M -1.5x 2.2x
Ascendis Pharma A/S ASND ██% $13.87B x x
Assertio Holdings, Inc. ASRT ██% $88M -0.2x 0.9x
Atai Beckley N.V. ATAI ██% $1.29B -4.4x 8.1x
Alterity Therapeutics Ltd ATHE ██% $66M x x
Actinium Pharmaceuticals, Inc. ATNM ██% $34M -4.1x 2.5x
Atossa Therapeutics, Inc. ATOS ██% $46M -6.2x 0.9x
Avenue Therapeutics, Inc. ATXI ██% $730K -9.5x 0.2x
Astria Therapeutics, Inc. ATXS ██% $710M -4.7x 3.0x
Aurinia Pharmaceuticals Inc. AUPH ██% $1.86B 6.5x 3.2x
Arrivent Biopharma, Inc. AVBP ██% $970M x 3.2x
Avadel Pharmaceuticals Plc AVDL ██% $2.10B -10.2x 21.4x
Atea Pharmaceuticals, Inc. AVIR ██% $469M -1.5x 1.7x
Avalo Therapeutics, Inc. AVTX ██% $263M -0.1x 2.9x
Axim Biotechnologies, Inc. AXIM ██% $2M x 0.5x
Axsome Therapeutics, Inc. AXSM ██% $8.08B -19.9x 91.6x
Aytu Biopharma, Inc AYTU ██% $27M -0.3x 1.2x
Azitra, Inc. AZTR ██% $3M -0.2x 0.7x
Bridgebio Pharma, Inc. BBIO ██% $13.35B -11.6x -5.4x
Bicara Therapeutics Inc. BCAX ██% $1.22B x 3.0x
Briacell Therapeutics Corp. BCTX ██% $33M -1.7x 1.1x
Bicycle Therapeutics Plc BCYC ██% $316M -6.0x 0.5x
Bioadaptives, Inc. BDPT ██% $130K x 11.0x
Beone Medicines Ltd. BEIGF ██% $36.38B 530.6x 8.8x
Bullfrog Ai Holdings, Inc. BFRG ██% $6M -2.9x 3.3x
Biofrontera Inc. BFRI ██% $10M -0.1x 1.0x
Bausch Health Companies Inc. BHC ██% $1.86B 11.8x 3.5x
Bioharvest Sciences Inc. BHST ██% $100M x 75.0x
Biohaven Ltd. BHVN ██% $1.35B -4.6x 25.9x
Bioage Labs, Inc. BIOA ██% $782M x 2.8x
Bio Essence Corp BIOE ██% $2M x x
Biovie Inc. BIVI ██% $11M -0.6x 0.6x
Bioxytran, Inc BIXT ██% $3M x 5.9x
Biolinerx Ltd. BLRX ██% $12M x x
Belite Bio, Inc BLTE ██% $6.08B x 67.3x
Biomea Fusion, Inc. BMEA ██% $77M -1.6x 4.9x
Biomarin Pharmaceutical Inc BMRN ██% $10.58B 30.3x 1.7x
Bristol Myers Squibb Co BMY ██% $118.20B 16.8x 6.4x
Bristol Myers Squibb Co BMYMP ██% $1.73T 287.0x 93.4x
Benitec Biopharma Inc. BNTC ██% $394M -0.6x 2.1x
Boundless Bio, Inc. BOLD ██% $27M -15.1x 0.3x
Bolt Biotherapeutics, Inc. BOLT ██% $9M -0.3x 0.3x
Bio-Path Holdings, Inc. BPTH ██% $550K 0.0x 3.6x
Bioquest Corp BQST ██% $14M x 2.8x
Barinthus Biotherapeutics Plc. BRNS ██% $26M -0.6x 0.4x
Bespoke Extracts, Inc. BSPK ██% $3M x 181.5x
Bioxcel Therapeutics, Inc. BTAI ██% $32M -0.1x 5.5x
Beyondspring Inc. BYSI ██% $72M 63.8x 1.3x
Calcimedica, Inc. CALC ██% $11M 0.4x 1.9x
Camp4 Therapeutics Corp CAMP ██% $268M -0.1x 5.6x
Can-Fite Biopharma Ltd. CANF ██% $7M x 1.7x
Capricor Therapeutics, Inc. CAPR ██% $1.77B x 5.8x
Carisma Therapeutics Inc. CARM ██% $2M 0.2x 0.0x
Casi Pharmaceuticals, Inc. CASI ██% $5M -1.4x 2.5x
Perspective Therapeutics, Inc. CATX ██% $524M -2.8x 2.5x
Crescent Biopharma, Inc. CBIO ██% $293M -6.5x 1.4x
Cdt Equity Inc. CDT ██% $2M -0.7x 0.4x
Cingulate Inc. CING ██% $82M -0.6x 32.7x
Cell Source, Inc. CLCS ██% $33M x 2940.6x
Clene Inc. CLNN ██% $71M -7.3x 16.7x
Cellectar Biosciences, Inc. CLRB ██% $13M x 1.6x
Clearside Biomedical, Inc. CLSD ██% $4M -2.0x -0.7x
Climb Bio, Inc. CLYM ██% $485M -1.4x 3.0x
Chemomab Therapeutics Ltd. CMMB ██% $12M 10.9x 1.2x
Clearmind Medicine Inc. CMND ██% $1M x x
Compass Pathways Plc CMPS ██% $650M 0.0x 17.3x
Cnbx Pharmaceuticals Inc. CNBX ██% $130K x 0.2x
Cns Pharmaceuticals, Inc. CNSP ██% $1M 0.0x 0.1x
Centessa Pharmaceuticals Plc CNTA ██% $3.81B -11.0x 12.6x
Connect Biopharma Holdings Ltd CNTB ██% $152M x 2.7x
Context Therapeutics Inc. CNTX ██% $268M -1.5x 3.7x
Cocrystal Pharma, Inc. COCP ██% $13M -1.0x 1.8x
Cogent Biosciences, Inc. COGT ██% $5.57B -3.7x 8.8x
Collegium Pharmaceutical, Inc COLL ██% $1.12B 17.9x 3.7x
Corcept Therapeutics Inc CORT ██% $3.61B 36.2x 5.6x
Coya Therapeutics, Inc. COYA ██% $99M -6.8x 2.3x
China Pharma Holdings, Inc. CPHI ██% $3M -0.2x 0.3x
Cumberland Pharmaceuticals Inc CPIX ██% $42M -4.5x 1.7x
Cannapharmarx, Inc. CPMD ██% $3M x 1.7x
Catalyst Pharmaceuticals, Inc. CPRX ██% $2.74B 12.8x 2.9x
Corbus Pharmaceuticals Holdings, Inc. CRBP ██% $157M -2.0x 1.1x
Cormedix Inc. CRMD ██% $495M 3.0x 1.2x
Crinetics Pharmaceuticals, Inc. CRNX ██% $3.42B -15.9x 3.5x
Cervomed Inc. CRVO ██% $39M -0.7x 2.2x
Corvus Pharmaceuticals, Inc. CRVS ██% $1.34B -13.7x 21.9x
Cytomx Therapeutics, Inc. CTMX ██% $813M 29.5x 8.2x
Contineum Therapeutics, Inc. CTNM ██% $452M x 1.7x
Citius Oncology, Inc. CTOR ██% $59M 3.9x 1.0x
Hepion Pharmaceuticals, Inc. CTRVP ██% $20K x 0.0x
Citius Pharmaceuticals, Inc. CTXR ██% $18M -5.3x 0.2x
Cue Biopharma, Inc. CUE ██% $26M -1.2x 1.0x
Cadrenal Therapeutics, Inc. CVKD ██% $16M -11.1x 6.0x
Cv Sciences, Inc. CVSI ██% $7M x 4.4x
Cyclerion Therapeutics, Inc. CYCN ██% $6M -5.2x 0.6x
Cytodyn Inc. CYDY ██% $342M 86.7x 123.5x
Cryoport, Inc. CYRX ██% $405M 5.2x 0.8x
Cytokinetics Inc CYTK ██% $7.75B -9.4x 71.4x
Dare Bioscience, Inc. DARE ██% $20M 2.9x 7.0x
Day One Biopharmaceuticals, Inc. DAWN ██% $2.20B -8.9x 5.0x
Journey Medical Corp DERM ██% $231M 24.1x 8.9x
Diamedica Therapeutics Inc. DMAC ██% $366M -4.2x 7.1x
Dianthus Therapeutics, Inc. /De/ DNTH ██% $3.46B -3.2x 7.0x
Dermata Therapeutics, Inc. DRMA ██% $4M -0.2x 1.0x
Bright Minds Biosciences Inc. DRUG ██% $684M x x
Design Therapeutics, Inc. DSGN ██% $622M -7.6x 2.9x
Dynavax Technologies Corp DVAX ██% $1.82B 88.2x 3.4x
Dogwood Therapeutics, Inc. DWTX ██% $81M -2.9x 1.1x
Dyne Therapeutics, Inc. DYN ██% $3.02B -7.8x 3.1x
Emergent Biosolutions Inc. EBS ██% $427M 8.1x 0.8x
Edesa Biotech, Inc. EDSA ██% $64M -1.3x 4.6x
Eagle Pharmaceuticals, Inc. EGRX ██% $4M 0.4x 0.0x
Pmgc Holdings Inc. ELAB ██% $2M -8.2x 0.2x
Elanco Animal Health Inc ELAN ██% $12.34B 341.6x 1.9x
Eledon Pharmaceuticals, Inc. ELDN ██% $239M x 6.8x
Elite Pharmaceuticals Inc /Nv/ ELTP ██% $403M 15.3x 5.0x
Elicio Therapeutics, Inc. ELTX ██% $213M -1.9x 130.4x
Enliven Therapeutics, Inc. ELVN ██% $1.79B -13.3x 3.9x
Emmaus Life Sciences, Inc. EMMA ██% $930K x 0.2x
Enlivex Ltd. ENLV ██% $256M x 13.5x
Ensysce Biosciences, Inc. ENSC ██% $2M x 1.7x
Enanta Pharmaceuticals Inc ENTA ██% $377M -1.3x 3.0x
Gridai Technologies Corp. ENTO ██% $7M 0.0x 0.3x
Enveric Biosciences, Inc. ENVB ██% $3M -0.1x 0.8x
Evolus, Inc. EOLS ██% $314M -13.1x 56.9x
Essa Pharma Inc. EPIX ██% $9M -2.7x 0.1x
Eupraxia Pharmaceuticals Inc. EPRX ██% $424M x 5.2x
Equillium, Inc. EQ ██% $130M -3.2x 4.2x
Erasca, Inc. ERAS ██% $4.34B -3.1x 13.3x
Ernexa Therapeutics Inc. ERNA ██% $7M x 3.1x
Esperion Therapeutics, Inc. ESPR ██% $643M -4.2x 71.8x
89bio, Inc. ETNB ██% $2.20B -3.5x 4.2x
Eton Pharmaceuticals, Inc. ETON ██% $562M -66.2x 21.5x
Earth Science Tech, Inc. ETST ██% $32M 15.3x 5.6x
Evofem Biosciences, Inc. EVFM ██% $1M 2.9x 0.1x
Edgewise Therapeutics, Inc. EWTX ██% $3.19B -19.7x 6.1x
Fuss Brands Corp. FBDS ██% $2M x 0.0x
Fortress Biotech, Inc. FBIO ██% $97M 24.4x 1.7x
Fortress Biotech, Inc. FBIOP ██% $394M 98.8x 7.1x
Fibrobiologics, Inc. FBLG ██% $17M x 2.8x
Forte Biosciences, Inc. FBRX ██% $311M -11.5x 3.7x
Fibrogen Inc FGEN ██% $35M 0.2x -3.6x
Foghorn Therapeutics Inc. FHTX ██% $276M -3.3x 2468.6x
Amicus Therapeutics, Inc. FOLD ██% $4.47B -8.5x 16.3x
Fulcrum Therapeutics, Inc. FULC ██% $461M -36.1x 1.3x
Galectin Therapeutics Inc GALT ██% $177M -2.4x 198.5x
Gain Therapeutics, Inc. GANX ██% $70M -1.4x 11.9x
Generation Bio Co. GBIO ██% $36M -0.6x 0.7x
Greater Cannabis Company, Inc. GCAN ██% $380K x x
Geron Corp GERN ██% $992M -11.9x 4.4x
Gh Research Plc GHRS ██% $963M x x
Galmed Pharmaceuticals Ltd. GLMD ██% $4M x 0.2x
Galapagos Nv GLPG ██% $2.22B x x
Greenwich Lifesciences, Inc. GLSI ██% $382M -17.2x 175.0x
Galecto, Inc. GLTO ██% $1.59B -2.5x 198.2x
Genelux Corp GNLX ██% $114M -2.8x 9.8x
Genprex, Inc. GNPX ██% $5M -3.2x 5.9x
Gossamer Bio, Inc. GOSS ██% $106M -3.2x 3.6x
Geovax Labs, Inc. GOVX ██% $3M x 0.6x
Structure Therapeutics Inc. GPCR ██% $3.57B -44.0x 2.4x
Grace Therapeutics, Inc. GRCE ██% $63M -3.9x 1.0x
Gri Bio, Inc. GRI ██% $4M -0.1x 0.6x
Galera Therapeutics, Inc. GRTX ██% $3M 0.0x 0.9x
Gsk Plc GSK ██% $104.38B x x
Gt Biopharma, Inc. GTBP ██% $14M x 2.3x
Gyre Therapeutics, Inc. GYRE ██% $710M 60.2x 7.0x
Hutchmed (China) Ltd HCM ██% $2.52B x 2.0x
Hcw Biologics Inc. HCWB ██% $4M x 0.5x
Hepion Pharmaceuticals, Inc. HEPA ██% $700K -0.1x 0.3x
Hutchmed (China) Ltd HMDCF ██% $2.64B x 2.1x
Hookipa Pharma Inc. HOOK ██% $14M -1.0x 0.4x
Hoth Therapeutics, Inc. HOTH ██% $15M -0.5x 1.8x
Werewolf Therapeutics, Inc. HOWL ██% $40M -1.3x 1.4x
Harmony Biosciences Holdings, Inc. HRMY ██% $1.61B 10.1x 1.9x
Heron Therapeutics, Inc. /De/ HRTX ██% $186M -6.4x 13.0x
Hst Global, Inc. HSTC ██% $35M x 28.3x
Tuhura Biosciences, Inc./Nv HURA ██% $96M x 5.7x
Ibio, Inc. IBIO ██% $72M -0.4x 1.3x
Impact Biomedical Inc. IBO ██% $48M x 3.8x
Ideaya Biosciences, Inc. IDYA ██% $2.92B -12.2x 2.9x
Inflarx N.V. IFRX ██% $60M x x
Igc Pharma, Inc. IGC ██% $27M -4.6x 3.3x
Immutep Ltd IMMP ██% $61M x x
Immix Biopharma, Inc. IMMX ██% $513M x 38.7x
Immunome Inc. IMNM ██% $2.33B -2.4x 3.7x
Imunon, Inc. IMNN ██% $10M -0.5x 2.4x
Immuron Ltd IMRN ██% $7M x x
Immuneering Corp IMRX ██% $363M -0.8x 1.7x
Eom Pharmaceutical Holdings, Inc. IMUC ██% $6M x 1.8x
Immunic, Inc. IMUX ██% $151M -0.8x 14.4x
Integrated Biopharma Inc INBP ██% $9M 14.8x 0.5x
Indaptus Therapeutics, Inc. INDP ██% $4M -0.6x 0.9x
Indivior Pharmaceuticals, Inc. INDV ██% $3.81B 18.2x x
Inmed Pharmaceuticals Inc. INM ██% $2M -51.8x 0.2x
Inovio Pharmaceuticals, Inc. INO ██% $109M -0.6x 4.5x
Insmed Inc INSM ██% $30.57B -14.0x 41.4x
Inhibitor Therapeutics, Inc. INTI ██% $15M x 4398.1x
Innoviva, Inc. INVA ██% $1.65B 6.1x 1.4x
Io Biotech, Inc. IOBT ██% $13M -0.7x 14.5x
Ionis Pharmaceuticals Inc IONS ██% $11.65B -14.6x 23.8x
Opus Genetics, Inc. IRD ██% $320M -2.0x 20.9x
Disc Medicine, Inc. IRON ██% $2.20B -18.4x 3.0x
Ironwood Pharmaceuticals Inc IRWD ██% $527M 21.9x 0.7x
International Stem Cell Corp ISCO ██% $1M x 0.4x
Iterum Therapeutics Plc ITRM ██% $9M -0.8x 2.7x
Inventiva S.A. IVA ██% $1.25B x x
Incannex Healthcare Inc. IXHL ██% $42M x 0.6x
Jaguar Health, Inc. JAGX ██% $5M -0.2x 1.0x
Janux Therapeutics, Inc. JANX ██% $848M -63.7x 0.9x
Jazz Pharmaceuticals Plc JAZZ ██% $11.17B 14.3x 2.6x
Jade Biosciences, Inc. JBIO ██% $690M x 2.1x
Johnson & Johnson JNJ ██% $566.63B 21.1x 7.2x
Jupiter Neurosciences, Inc. JUNS ██% $13M x 225.3x
Kala Bio, Inc. KALA ██% $224M -0.5x 39.3x
Kalvista Pharmaceuticals, Inc. KALV ██% $859M -2.6x 50.6x
Kairos Pharma, Ltd. KAPA ██% $13M x 1.7x
Kaya Holdings, Inc. KAYS ██% $23M x x
Kamada Ltd KMDA ██% $490M x x
Kiniksa Pharmaceuticals International, Plc KNSA ██% $3.39B 57.4x 6.0x
Kiora Pharmaceuticals Inc KPRX ██% $7M -2.4x 0.3x
Karyopharm Therapeutics Inc. KPTI ██% $142M -0.6x 2.8x
Keros Therapeutics, Inc. KROS ██% $339M 3.9x 1.1x
Korro Bio, Inc. KRRO ██% $104M -7.9x 1.6x
Pasithea Therapeutics Corp. KTTA ██% $18M -73.5x 1.5x
Kura Oncology, Inc. KURA ██% $741M -4.5x 4.3x
Kezar Life Sciences, Inc. KZR ██% $49M -3.2x 0.6x
Legend Biotech Corp LEGN ██% $3.43B x x
Lexaria Bioscience Corp. LEXX ██% $18M -29.3x 3.7x
Lifecore Biomedical, Inc. \De\ LFCR ██% $152M x 113.9x
Lifevantage Corp LFVN ██% $60M 7.7x 1.8x
Ligand Pharmaceuticals Inc LGND ██% $4.16B 33.4x 4.1x
Longeveron Inc. LGVN ██% $32M -0.5x 5.7x
Lianbio LIANY ██% $18M x 0.1x
Lftd Partners Inc. LIFD ██% $4M 56.1x 0.1x
Lipella Pharmaceuticals Inc. LIPO ██% $730K -3.3x 0.5x
Lixte Biotechnology Holdings, Inc. LIXT ██% $26M -0.9x 5.3x
Lixte Biotechnology Holdings, Inc. LIXTW ██% $130K x 0.0x
Eli Lilly & Co LLY ██% $823.27B 39.9x 31.0x
Lipocine Inc. LPCN ██% $43M -2.6x 2.9x
Cypherpunk Technologies Inc. LPTX ██% $94M -1.1x 35.1x
Liquidia Corp LQDA ██% $3.26B -7.2x 72.8x
Larimar Therapeutics, Inc. LRMR ██% $463M -0.8x 5.9x
Lisata Therapeutics, Inc. LSTA ██% $44M -1.0x 3.0x
Lantern Pharma Inc. LTRN ██% $26M -2.4x 2.7x
Lava Therapeutics Nv LVTX ██% $46M x 3.6x
Lexicon Pharmaceuticals, Inc. LXRX ██% $686M -1.2x 6.4x
Lyell Immunopharma, Inc. LYEL ██% $428M -1.1x 1.7x
Maia Biotechnology, Inc. MAIA ██% $88M -1.4x 2111.6x
Mustang Bio, Inc. MBIO ██% $6M -0.1x 0.7x
Moleculin Biotech, Inc. MBRX ██% $11M -2.3x 253.7x
Mbx Biosciences, Inc. MBX ██% $1.34B x 3.6x
Seres Therapeutics, Inc. MCRB ██% $87M 15.2x 2.0x
Medicus Pharma Ltd. MDCX ██% $13M x x
Medicus Pharma Ltd. MDCXW ██% $52M x x
Madrigal Pharmaceuticals, Inc. MDGL ██% $10.38B -5.7x 17.2x
Chrome Holding Co. MEHCQ ██% $96M x x
Macrogenics Inc MGNX ██% $184M -2.1x 3.3x
Mira Pharmaceuticals, Inc. MIRA ██% $43M -1.6x 5.7x
Mirum Pharmaceuticals, Inc. MIRM ██% $5.83B -20.0x 18.5x
Milestone Pharmaceuticals Inc. MIST ██% $145M -2.0x 7.1x
Moonlake Immunotherapeutics MLTX ██% $1.20B -50.8x 4.0x
Mineralys Therapeutics, Inc. MLYS ██% $1.90B -4.5x 2.9x
Mannkind Corp MNKD ██% $776M 132.3x 44.2x
Medicinova Inc MNOV ██% $68M -7.1x 1.7x
Monopar Therapeutics MNPR ██% $391M -3.0x 2.8x
Mereo Biopharma Group Plc MREO ██% $57M x 1.4x
Merck & Co., Inc. MRK ██% $289.91B 15.9x 5.5x
Marker Therapeutics, Inc. MRKR ██% $22M -0.6x 1.3x
Mersana Therapeutics, Inc. MRSN ██% $145M -3.4x -1.4x
Merus N.V. MRUS ██% $6.83B -13.5x 8.8x
Maravai Lifesciences Holdings, Inc. MRVI ██% $1.11B -5.6x 5.3x
Matinas Biopharma Holdings, Inc. MTNB ██% $3M -1.7x 0.5x
Metsera, Inc. MTSR ██% $7.41B x 22.0x
Metavia Inc. MTVA ██% $5M -0.5x 0.8x
Mural Oncology Plc MURA ██% $35M x 0.6x
Mainz Biomed N.V. MYNZ ██% $7M x x
Newamsterdam Pharma Co N.V. NAMS ██% $3.48B x 5.1x
Newamsterdam Pharma Co N.V. NAMSW ██% $2.59B x 3.6x
Natures Sunshine Products Inc NATR ██% $421M 21.5x 2.6x
Novabay Pharmaceuticals, Inc. NBY ██% $31M 8.0x 27.7x
Nucana Plc NCNA ██% $8M x x
Minerva Neurosciences, Inc. NERV ██% $340M -0.8x 42.6x
Neuphoria Therapeutics Inc. NEUP ██% $25M x 0.8x
Neurogene Inc. NGNE ██% $284M -7.3x 1.1x
Nika Pharmaceuticals, Inc NIKA ██% $786M x 192879.0x
Nektar Therapeutics NKTR ██% $2.10B -1.2x 23.4x
Nkarta, Inc. NKTX ██% $161M -1.3x 0.5x
Newcelx Ltd. NLSP ██% $54M x 98.9x
Newcelx Ltd. NLSPW ██% $120K x 0.2x
Nanoviricides, Inc. NNVC ██% $23M -2.1x 2.1x
Nurix Therapeutics, Inc. NRIX ██% $1.52B -7.4x 2.8x
Neurosense Therapeutics Ltd. NRSN ██% $26M x x
Nrx Pharmaceuticals, Inc. NRXP ██% $62M -0.6x 8.4x
Neonc Technologies Holdings, Inc. NTHI ██% $216M x x
Nuvation Bio Inc. NUVB ██% $1.46B -1.2x 4.8x
Nuvalent, Inc. NUVL ██% $7.05B -30.9x 5.7x
Nuvectis Pharma, Inc. NVCT ██% $223M -3.9x 12.1x
Novartis Ag NVS ██% $282.77B x x
Northwest Biotherapeutics Inc NWBO ██% $334M x x
Nexien Biopharma, Inc. NXEN ██% $10K x x
Nextcure, Inc. NXTC ██% $43M -0.5x 1.2x
Ocean Biomedical, Inc. OCEA ██% $210K -0.3x 0.1x
Ocular Therapeutix, Inc OCUL ██% $1.79B -8.2x 2.7x
Oragenics Inc OGEN ██% $3M -0.1x 0.4x
Organigram Global Inc. OGI ██% $190M x x
Organon & Co. OGN ██% $1.63B 8.7x 2.2x
Onkure Therapeutics, Inc. OKUR ██% $59M -6.9x 1.1x
Olema Pharmaceuticals, Inc. OLMA ██% $1.20B -4.0x 2.5x
Omeros Corp OMER ██% $779M -4.2x 38.0x
Beone Medicines Ltd. ONC ██% $32.47B 113.2x 7.5x
Onconetix, Inc. ONCO ██% $820K -0.3x 0.0x
Oncolytics Biotech Inc ONCY ██% $105M x x
Opko Health, Inc. OPK ██% $879M -3.5x 0.7x
Organogenesis Holdings Inc. ORGO ██% $305M 8.2x 1.0x
Orgenesis Inc. ORGS ██% $2M 0.9x 0.1x
Oric Pharmaceuticals, Inc. ORIC ██% $1.24B -4.2x 3.2x
Oruka Therapeutics, Inc. ORKA ██% $1.89B x 4.0x
Oramed Pharmaceuticals Inc. ORMP ██% $147M 3.4x 0.7x
Os Therapies Inc OSTX ██% $50M x 13.7x
Oncotelic Therapeutics, Inc. OTLC ██% $17M x 1.9x
Ovid Therapeutics Inc. OVID ██% $167M -2.6x 1.3x
One World Products, Inc. OWPC ██% $720K x 0.6x
Phibro Animal Health Corp PAHC ██% $2.12B 23.1x 6.4x
Prestige Consumer Healthcare Inc. PBH ██% $2.93B 15.7x 1.6x
Psyence Biomedical Ltd. PBM ██% $5M x x
Puma Biotechnology, Inc. PBYI ██% $310M 10.0x 2.4x
Pacira Biosciences, Inc. PCRX ██% $928M 131.9x 1.3x
Processa Pharmaceuticals, Inc. PCSA ██% $5M -0.5x 1.0x
Procyon Corp PCYN ██% $980K x 0.4x
Pds Biotechnology Corp PDSB ██% $34M -1.7x 3.6x
Pepgen Inc. PEPG ██% $329M -1.6x 2.2x
Pfizer Inc PFE ██% $154.61B 19.9x 1.8x
Precigen, Inc. PGEN ██% $1.17B -1.4x 28.1x
Phathom Pharmaceuticals, Inc. PHAT ██% $796M -1.6x 45.3x
Phio Pharmaceuticals Corp. PHIO ██% $14M -0.8x 0.7x
Pharvaris N.V. PHVS ██% $1.71B x x
Protokinetix, Inc. PKTX ██% $2M x 7.8x
Plandai Biotechnology, Inc. PLPL ██% $4M x 14.6x
Pliant Therapeutics, Inc. PLRX ██% $82M -4.5x 0.5x
Polomar Health Services, Inc. PMHS ██% $2M x 0.2x
Promis Neurosciences Inc. PMN ██% $39M -2.1x 4.3x
Pmv Pharmaceuticals, Inc. PMVP ██% $79M -1.6x 0.8x
Purple Biotech Ltd. PPBT ██% $4M x x
Propanc Biopharma, Inc. PPCB ██% $2M x 0.2x
Praxis Precision Medicines, Inc. PRAX ██% $7.70B -4.0x 8.8x
Prf Technologies Ltd. PRFX ██% $2M x 0.3x
Perrigo Co Plc PRGO ██% $1.35B -27.6x 0.5x
Prelude Therapeutics Inc PRLD ██% $204M -0.5x 3.0x
Prophase Labs, Inc. PRPH ██% $360K -0.5x 0.1x
Proqr Therapeutics N.V. PRQR ██% $168M x x
Prothena Corp Public Ltd Co PRTA ██% $462M -12.4x 1.7x
Ptc Therapeutics, Inc. PTCT ██% $5.47B 8.0x 3805.7x
Protagonist Therapeutics, Inc PTGX ██% $5.99B 119.5x 9.7x
Protagenic Therapeutics, Inc.\New PTIX ██% $1M -2.8x 1.2x
Palatin Technologies Inc PTNT ██% $17M x 43.1x
Petros Pharmaceuticals, Inc. PTPI ██% $300K -0.1x 0.1x
Pulmatrix, Inc. PULM ██% $8M -1.8x 2.1x
Provectus Biopharmaceuticals, Inc. PVCT ██% $23M x 6.5x
Palvella Therapeutics, Inc. PVLA ██% $1.66B x 43.0x
Pyxis Oncology, Inc. PYXS ██% $94M -1.3x 1.4x
Aixcrypto Holdings, Inc. QLGN ██% $8M -1.3x 0.2x
Quoin Pharmaceuticals, Ltd. QNRX ██% $13M x 5.2x
Quantum Biopharma Ltd. QNTM ██% $9M x x
Q32 Bio Inc. QTTB ██% $96M 3.2x 2.3x
Uniqure N.V. QURE ██% $964M -2.8x 4.9x
Radiopharm Theranostics Ltd RADX ██% $36M x x
Rani Therapeutics Holdings, Inc. RANI ██% $139M -1.3x 69.7x
Rapport Therapeutics, Inc. RAPP ██% $1.32B x 2.7x
Rapt Therapeutics, Inc. RAPT ██% $1.56B -0.4x 10.3x
Ultragenyx Pharmaceutical Inc. RARE ██% $2.00B -7.0x 218.2x
Rocket Pharmaceuticals, Inc. RCKT ██% $489M -4.8x 1.8x
Arcus Biosciences, Inc. RCUS ██% $2.78B -5.5x 4.4x
Dr Reddys Laboratories Ltd RDY ██% $11.61B x x
Regeneron Pharmaceuticals, Inc. REGN ██% $77.07B 17.1x 2.5x
Revelation Biosciences, Inc. REVB ██% $4M -0.1x 0.5x
Rafael Holdings, Inc. RFL ██% $66M -0.9x 0.8x
Regen Biopharma Inc RGBP ██% $130K x 1.5x
Regen Biopharma Inc RGBPP ██% $470K x x
Rigel Pharmaceuticals Inc RIGL ██% $471M 1.3x 1.2x
Relmada Therapeutics, Inc. RLMD ██% $459M -0.1x 5.3x
Rallybio Corp RLYB ██% $53M -0.7x 0.8x
Retrieve Medical Holdings, Inc. RMHI ██% $60M x 793.6x
Rockwell Medical, Inc. RMTI ██% $39M -17.1x 1.1x
Avidity Biosciences, Inc. RNA ██% $200M -12.2x 0.1x
Cartesian Therapeutics, Inc. RNAC ██% $173M -2.1x 230.0x
Transcode Therapeutics, Inc. RNAZ ██% $8M -0.2x 5.4x
Rein Therapeutics, Inc. RNTX ██% $32M x 0.7x
Renovorx, Inc. RNXT ██% $37M -3.4x 4.6x
Roivant Sciences Ltd. ROIV ██% $19.56B 1.8x 4.6x
Royalty Pharma Plc RPRX ██% $26.05B 33.8x 4.0x
Repare Therapeutics Inc. RPTX ██% $114M -2.1x 1.0x
Rest Ez Inc. RTEZ ██% $1.93B x 6425307.7x
Rapid Therapeutic Science Laboratories, Inc. RTSL ██% $110K 1.9x 0.3x
Reviva Pharmaceuticals Holdings, Inc. RVPH ██% $12M -4.1x 2.7x
Rhythm Pharmaceuticals, Inc. RYTM ██% $6.14B -20.3x 44.2x
Rezolute, Inc. RZLT ██% $233M -3.9x 1.8x
Filana Therapeutics, Inc. SAVA ██% $101M -1.9x 1.2x
Sunshine Biopharma Inc. SBFM ██% $5M -0.6x 0.2x
Scienture Holdings, Inc. SCNX ██% $18M 2.9x 0.2x
Scpharmaceuticals Inc. SCPH ██% $302M -2.0x -50.9x
Scorpius Holdings, Inc. SCPX ██% $770K 0.0x 0.0x
Scynexis Inc SCYX ██% $40M -2.4x 0.8x
Schrodinger, Inc. SDGR ██% $893M -7.8x 2.5x
Septerna, Inc. SEPN ██% $1.07B x 2.8x
Serina Therapeutics, Inc. SER ██% $28M 22.6x 15.8x
Sagimet Biosciences Inc. SGMT ██% $158M x 1.4x
Shuttle Pharmaceuticals Holdings, Inc. SHPH ██% $5M x 3.7x
Siga Technologies Inc SIGA ██% $355M 15.2x 1.8x
Silo Pharma, Inc. SILO ██% $5M x 0.9x
Sionna Therapeutics, Inc. SION ██% $1.65B x 5.4x
Skinvisible, Inc. SKVI ██% $1M x x
Skye Bioscience, Inc. SKYE ██% $22M -0.7x 1.1x
Sol-Gel Technologies Ltd. SLGL ██% $228M x 10.0x
Silence Therapeutics Plc SLN ██% $318M x 5.1x
Silence Therapeutics Plc SLNCF ██% $213M x 2.9x
Soleno Therapeutics Inc SLNO ██% $1.75B 83.8x 3.9x
Salarius Pharmaceuticals, Inc. SLRX ██% $2M -0.5x 0.4x
Sellas Life Sciences Group, Inc. SLS ██% $885M -1.0x 19.4x
Summit Therapeutics Inc. SMMT ██% $12.58B 104.1x 19.1x
Syndax Pharmaceuticals Inc SNDX ██% $2.09B -4.1x 32.3x
Soligenix, Inc. SNGX ██% $12M -1.8x 1.6x
Sibannac, Inc. SNNC ██% $830K x 1.8x
Sensei Biotherapeutics, Inc. SNSE ██% $40M -0.4x 1.8x
Sanofi SNY ██% $106.00B x x
Sonnet Biotherapeutics Holdings, Inc. SONN ██% $4M -1.6x 29.5x
Spruce Biosciences, Inc. SPRB ██% $82M -0.4x 1.9x
Scisparc Ltd. SPRC ██% $2M x x
Spero Therapeutics, Inc. SPRO ██% $139M -17.8x 5.2x
Ars Pharmaceuticals, Inc. SPRY ██% $828M -23.5x 7.3x
Sarepta Therapeutics, Inc. SRPT ██% $1.80B 162.5x 1.6x
Stoke Therapeutics, Inc. STOK ██% $2.03B 45.5x 5.8x
Shattuck Labs, Inc. STTK ██% $442M x 5.4x
Supernus Pharmaceuticals, Inc. SUPN ██% $2.85B 46.0x 2.7x
Savara Inc SVRA ██% $1.03B -8.2x 5.1x
60 Degrees Pharmaceuticals, Inc. SXTP ██% $2M -0.6x 0.6x
Synlogic, Inc. SYBX ██% $8M 3.6x 0.7x
Spyre Therapeutics, Inc. SYRE ██% $3.36B -0.7x 4.7x
Syros Pharmaceuticals, Inc. SYRS ██% $20K -0.1x -0.4x
Takeda Pharmaceutical Co Ltd TAK ██% $56.59B x x
Theravance Biopharma, Inc. TBPH ██% $711M 24.2x 3.1x
Alaunos Therapeutics, Inc. TCRT ██% $7M -1.0x 2.6x
Telomir Pharmaceuticals, Inc. TELO ██% $45M x 7.6x
Tenax Therapeutics, Inc. TENX ██% $250M -14.9x 2.6x
Terns Pharmaceuticals, Inc. TERN ██% $5.29B -5.1x 18.6x
Teva Pharmaceutical Industries Ltd TEVA ██% $33.37B 23.7x 4.2x
Teva Pharmaceutical Industries Ltd TEVJF ██% $38.09B 53.4x 5.3x
Tg Therapeutics, Inc. TGTX ██% $4.67B 10.4x 7.2x
Canton Strategic Holdings, Inc. THAR ██% $186M x 30.2x
Talphera, Inc. TLPH ██% $37M -2.3x 1.9x
Telix Pharmaceuticals Ltd TLX ██% $2.87B x x
Tango Therapeutics, Inc. TNGX ██% $2.60B -2.8x 7.5x
Tonix Pharmaceuticals Holding Corp. TNXP ██% $207M 0.0x 0.8x
Theriva Biologics, Inc. TOVX ██% $9M -0.4x 0.1x
Tempest Therapeutics, Inc. TPST ██% $30M -0.5x 4.7x
Traws Pharma, Inc. TRAW ██% $17M -0.6x 1.5x
Entrada Therapeutics, Inc. TRDA ██% $433M 6.9x 1.4x
Trevi Therapeutics, Inc. TRVI ██% $1.38B -6.1x 7.5x
Trevena Inc TRVN ██% $260K -1.3x 1.5x
Tvardi Therapeutics, Inc. TVRD ██% $33M x 1.2x
Travere Therapeutics, Inc. TVTX ██% $2.45B x 21.3x
Therapeuticsmd, Inc. TXMD ██% $26M 517.4x 0.9x
Tyra Biosciences, Inc. TYRA ██% $2.09B -9.5x 8.1x
Unicycive Therapeutics, Inc. UNCY ██% $141M -0.9x 3.8x
Upstream Bio, Inc. UPB ██% $468M x 1.2x
Urogen Pharma Ltd. URGN ██% $894M -2.5x 35.0x
United Therapeutics Corp UTHR ██% $22.82B 17.1x 3.2x
Vaccinex, Inc. VCNX ██% $3M -0.1x 0.4x
Vera Therapeutics, Inc. VERA ██% $2.65B -20.4x 4.4x
Veru Inc. VERU ██% $39M -0.8x 2.1x
Vicapsys Life Sciences, Inc. VICP ██% $49M x x
Vincerx Pharma, Inc. VINC ██% $70K -0.2x 0.0x
Viracta Therapeutics, Inc. VIRX ██% $390K -0.2x 0.2x
Viking Therapeutics, Inc. VKTX ██% $3.77B -67.5x 5.9x
Vanda Pharmaceuticals Inc. VNDA ██% $506M -16.1x 1.6x
Verrica Pharmaceuticals Inc. VRCA ██% $98M -0.5x 4.0x
Viridian Therapeutics, Inc.\De VRDN ██% $2.77B -4.5x 3.8x
Vireo Growth Inc. VREOF ██% $348M x 1.4x
Verona Pharma Plc VRNA ██% $73.55B -185.1x 264.3x
Virpax Pharmaceuticals, Inc. VRPX ██% $160K 0.0x -19.5x
Vertex Pharmaceuticals Inc / Ma VRTX ██% $115.58B 29.2x 6.2x
Verastem, Inc. VSTM ██% $493M -6.5x 8.6x
Vistagen Therapeutics, Inc. VTGN ██% $22M -0.1x 0.4x
Viatris Inc VTRS ██% $16.17B -29.5x 0.0x
Vtv Therapeutics Inc. VTVT ██% $0.00M -3.3x -7.5x
Ventyx Biosciences, Inc. VTYX ██% $999M -1.0x 5.2x
Vyne Therapeutics Inc. VYNE ██% $20M -0.4x 0.7x
Whitehawk Therapeutics, Inc. WHWK ██% $180M x 1.3x
Wave Life Sciences Ltd. WVE ██% $2.21B -22.2x 4.3x
Xenetic Biosciences, Inc. XBIO ██% $7M x 1.0x
Xbiotech Inc. XBIT ██% $72M -3.5x 0.5x
Exicure, Inc. XCUR ██% $28M -1.9x 4.0x
Xenon Pharmaceuticals Inc. XENE ██% $5.22B -15.4x 9.0x
Xeris Biopharma Holdings, Inc. XERS ██% $901M 1626.8x 65.8x
Xilio Therapeutics, Inc. XLO ██% $558M -0.5x 79.0x
Xencor Inc XNCR ██% $862M -8.4x 1.4x
Xoma Royalty Corp XOMA ██% $341M 10.7x 4.1x
Xoma Royalty Corp XOMAO ██% $312M 14.4x 3.6x
Xoma Royalty Corp XOMAP ██% $326M 15.1x 3.7x
Xtl Biopharmaceuticals Ltd XTLB ██% $6M x x
Zenas Biopharma, Inc. ZBIO ██% $1.22B x 5.0x
Zai Lab Ltd ZLAB ██% $2.00B -95.2x 2.8x
Zentalis Pharmaceuticals, Inc. ZNTL ██% $170M -1.4x 0.7x
Zomedica Corp. ZOMDF ██% $132M x 1.1x
Zoetis Inc. ZTS ██% $49.14B 18.4x 14.8x
Zevra Therapeutics, Inc. ZVRA ██% $525M 6.3x 3.4x
Zyversa Therapeutics, Inc. ZVSA ██% $2M x 0.3x
Zymeworks Inc. ZYME ██% $1.75B -8.3x 6.5x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Zentalis Pharmaceuticals, Inc. Stock Forecast

How accurate are Zentalis Pharmaceuticals, Inc. stock predictions?

Our AI model shows a 27% Spearman correlation coefficient for ZNTL predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Zentalis Pharmaceuticals, Inc. stock price forecasts?

Our analysis considers Zentalis Pharmaceuticals, Inc.'s financial metrics, Life Sciences sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Zentalis Pharmaceuticals, Inc. a good investment in 2025?

Based on our AI analysis, Zentalis Pharmaceuticals, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Zentalis Pharmaceuticals, Inc. forecasts updated?

Zentalis Pharmaceuticals, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

My Portfolio

Investment Dashboard

Loading your portfolio...